Condra, K S <br/><br/>
Adjuvant 32P in the treatment of ovarian carcinoma.  [electronic resource] 

 -  Radiation oncology investigations  1997 
 - 300-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1065-7541 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1520-6823(1997)5:6<300::AID-ROI6>3.0.CO;2-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Ovarian Neoplasms--mortality<br/>Phosphorus Radioisotopes--adverse effects<br/>Prognosis<br/>Radiotherapy, Adjuvant<br/>Survival Rate